Type 2 diabetes (T2D) is a global metabolic epidemic driven by insulin resistance (IR), chronic inflammation, and β-cell ...

Type 2 diabetes (T2D) is a global metabolic epidemic driven by insulin resistance (IR), chronic inflammation, and β-cell failure. This review ...

Explores Behemoth Labz GLP‑1 nasal formulation's structural design, analytic insights, and intranasal incretin research relevance in preclinical metabolic ...

Formulated with AMPK-activating botanicals and GLUT-4 support compounds, Glucorem explores how non-stimulant glucose ...

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not ...

Metabolic Syndrome (MetS), characterized by abdominal obesity, hypertension, dyslipidemia, and insulin resistance, represents a global health crisis ...

University of Pennsylvania and Syracuse University scientists have discovered that a hindbrain-derived peptide, octadecaneuropeptide (ODN), can suppress appetite and improve glucose regulation without ...

Insulin resistance is a hallmark of multiple metabolic disorders, including type 2 diabetes, obesity, metabolic syndrome, and polycystic ovary syndrome. It ...

Radella Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing innovative therapies for cardiometabolic disorders, today announced that its Phase 1b clinical trial of MD-18 ...

What makes sesame seeds a superfood? Their unique blend of healthy fats, antioxidants, and nutrients supports heart, metabolic, and skin health!

A new drug that skips neurons and targets support cells cut weight and improved insulin response in lab animals, without ...